Literature DB >> 17105839

Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women.

Melania Manco1, J Manuel Fernandez-Real, Francesco Equitani, Joan Vendrell, Maria Elena Valera Mora, Giuseppe Nanni, Vincenzo Tondolo, Menotti Calvani, Wilfredo Ricart, Marco Castagneto, Geltrude Mingrone.   

Abstract

CONTEXT: Obesity may be regarded as a low-grade inflammatory state.
OBJECTIVE: The aim of this study was to evaluate changes in pro-inflammatory adipocytokines and the innate immune system, cardiovascular risk, and insulin sensitivity after massive weight loss.
DESIGN: This was a longitudinal study.
SETTING: The study was conducted at Catholic University, Rome. SUBJECTS AND METHODS: There were 10 normoglucose-tolerant obese women evaluated before and 36 months after bilio-pancreatic diversion (BPD). Glucose sensitivity (M value) was estimated using the euglycemic-hyperinsulinemic clamp. Mannan-binding lectin (MBL), bactericidal/permeability increasing protein (BPI), alpha-defensins, soluble CD14 receptor (sCD14), C-reactive protein, adiponectin, leptin, visfatin, IL-6, and TNF-alpha were assayed.
RESULTS: After massive weight loss (53% of excess body weight), leptin (P <or= 0.0001), IL-6 (P <or= 0.0001), alpha-defensins (P <or= 0.001), and C-reactive protein (P <or= 0.0001) decreased significantly. Adiponectin increased significantly (P <or= 0.001). Of the nine subjects who lost more than 20% of body mass index, sCD14 (2.87 +/- 0.5 to 2.55 +/- 0.5; P = 0.016) and visfatin levels (12.20 +/- 0.93 to 10.63 +/- 1.93 ng/ml; P = 0.045) decreased significantly. No significant changes were observed in TNF-alpha, BPI, or MBL. Insulin sensitivity more than doubled after BPD (P <or= 0.0001). sCD14 changes were significantly associated with body mass index (r0 = 0.80; P = 0.003) and M changes (r0 = -0.59; P = 0.03). MBL correlated with insulin sensitivity in obese (r0 = 0.93; P = 0.0001) and post-BPD women (r(0) = 0.66; P = 0.038). Adiponectin correlated negatively with cardiovascular risk (r0 = -0.709; P = 0.02) and IL-6 (r0 = -0.634; P = 0.05). Multiple linear regression analysis showed that changes in sCD14 were also significantly related to changes in insulin sensitivity.
CONCLUSIONS: Surgically induced weight loss is capable of reversing low-grade inflammation, at least partially. The relationships between sCD14, MBL, BPI, and glucose sensitivity, and the role of TNF-alpha in obesity warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105839     DOI: 10.1210/jc.2006-0960

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  43 in total

1.  Omental gene expression of adiponectin correlates with degree of insulin sensitivity before and after gastric bypass surgery.

Authors:  Jiegen Chen; Anna Spagnoli; Alfonso Torquati
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

2.  Differential inflammatory status in rats susceptible or resistant to diet-induced obesity: effects of EPA ethyl ester treatment.

Authors:  Nerea Pérez-Echarri; Patricia Pérez-Matute; Beatriz Marcos-Gómez; Maria J Baena; Amelia Marti; J Alfredo Martínez; María Jesus Moreno-Aliaga
Journal:  Eur J Nutr       Date:  2008-09-18       Impact factor: 5.614

3.  Immune and Inflammatory Signaling Pathways in Exercise and Obesity.

Authors:  Karsten Krüger; Frank C Mooren; Klaus Eder; Robert Ringseis
Journal:  Am J Lifestyle Med       Date:  2014-10-27

4.  Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.

Authors:  Surya Prakash Bhatt; Randeep Guleria; Naval K Vikram; A K Gupta
Journal:  Sleep Breath       Date:  2018-07-22       Impact factor: 2.816

5.  Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.

Authors:  Vsevolod Y Polotsky; Susheel P Patil; Vladimir Savransky; Alison Laffan; Shannon Fonti; Leigh A Frame; Kimberly E Steele; Michael A Schweizter; Jeanne M Clark; Michael S Torbenson; Alan R Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2008-10-31       Impact factor: 21.405

6.  Morbid obesity and inflammation: a prospective study after adjustable gastric banding surgery.

Authors:  Renata Ramalho; Cristina Guimarães; Cidália Gil; Celestino Neves; João Tiago Guimarães; Luís Delgado
Journal:  Obes Surg       Date:  2009-05-14       Impact factor: 4.129

7.  Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss.

Authors:  Eva Solá; Ana Jover; Antonio López-Ruiz; María Jarabo; Amparo Vayá; Carlos Morillas; Marcelino Gómez-Balaguer; Antonio Hernández-Mijares
Journal:  Obes Surg       Date:  2008-12-03       Impact factor: 4.129

Review 8.  Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.

Authors:  Konstantinos Tziomalos; Hariklia V Dimitroula; Niki Katsiki; Christos Savopoulos; Apostolos I Hatzitolios
Journal:  Mediators Inflamm       Date:  2010-03-07       Impact factor: 4.711

9.  Maternal visfatin concentration in normal pregnancy.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

10.  The novel adipocytokine visfatin exerts direct cardioprotective effects.

Authors:  Shiang Y Lim; Sean M Davidson; Ajeev J Paramanathan; Christopher C T Smith; Derek M Yellon; Derek J Hausenloy
Journal:  J Cell Mol Med       Date:  2008-04-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.